Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders +1
1new positions
0sold out
1famous investor
$15.52avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, up 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($557K), UBS Group AG ($450) and Bank of America Corp. ($315). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $315 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,124 shares bought, net +1,124 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Add +2.6% | 35,676 | $557K |
| UBS Group AG | — | Add +257.5% | 143 | $450 |
| Bank of America Corp. | — | New | 100 | $315 |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.